Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.

Roberta Mancuso, Simone Agostini, Ambra Hernis, Domenico Caputo and 3 more